Hologic, Inc. (HOLX)
NASDAQ: HOLX · Real-Time Price · USD
75.46
+0.01 (0.01%)
At close: Mar 3, 2026, 4:00 PM EST
75.40
-0.06 (-0.08%)
After-hours: Mar 3, 2026, 7:47 PM EST
Hologic Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Hologic stock have an average target of 77.89, with a low estimate of 70 and a high estimate of 87. The average target predicts an increase of 3.22% from the current stock price of 75.46.
Analyst Consensus: Hold
* Price targets were last updated on Jan 5, 2026.
Analyst Ratings
The average analyst rating for Hologic stock from 13 stock analysts is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 1 | 1 |
| Buy | 5 | 2 | 2 | 2 | 1 | 1 |
| Hold | 7 | 11 | 11 | 11 | 11 | 11 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 14 | 15 | 15 | 15 | 13 | 13 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Argus Research | Argus Research | Strong Buy → Hold Downgrades n/a | Strong Buy → Hold | Downgrades | n/a | n/a | Jan 12, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy → Hold Downgrades $79 → $78 | Buy → Hold | Downgrades | $79 → $78 | +3.37% | Jan 5, 2026 |
| Morgan Stanley | Morgan Stanley | Hold Maintains $69 → $76 | Hold | Maintains | $69 → $76 | +0.72% | Nov 11, 2025 |
| Mizuho | Mizuho | Buy → Hold Downgrades $70 → $78 | Buy → Hold | Downgrades | $70 → $78 | +3.37% | Oct 23, 2025 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Oct 22, 2025 |
Financial Forecast
Revenue This Year
4.30B
from 4.10B
Increased by 4.74%
Revenue Next Year
4.51B
from 4.30B
Increased by 5.03%
EPS This Year
4.59
from 2.49
Increased by 84.41%
EPS Next Year
5.03
from 4.59
Increased by 9.57%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.5B | 4.7B | |||
| Avg | 4.3B | 4.5B | |||
| Low | 4.1B | 4.3B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 9.0% | 9.7% | |||
| Avg | 4.7% | 5.0% | |||
| Low | -0.2% | -0.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.87 | 5.44 | |||
| Avg | 4.59 | 5.03 | |||
| Low | 4.28 | 4.50 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 95.7% | 18.4% | |||
| Avg | 84.4% | 9.6% | |||
| Low | 72.0% | -2.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.